# Giuseppe Pelosi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giuseppe-pelosi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,337 |
| Field | Lung Cancer Research Studies |
| h-index | 74 |
| i10-index | 274 |
| Last Known Institution | University of Milan |
| OpenAlex ID | https://openalex.org/A5048676751 |
| ORCID iD | https://orcid.org/0000-0003-4725-4692 |
| Works | 526 |

## Researcher papers

- [PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project](https://scholariq.org/papers/pd-l1-immunohistochemistry-comparability-study-in-real-life-clinical-samples/)
- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/a-grading-system-for-invasive-pulmonary-adenocarcinoma-a-proposal-from-the/)
- [IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy](https://scholariq.org/papers/iaslc-multidisciplinary-recommendations-for-pathologic-assessment-of-lung-cancer/)
- [Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer](https://scholariq.org/papers/best-practices-recommendations-for-diagnostic-immunohistochemistry-in-lung/)
- [PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee](https://scholariq.org/papers/pd-l1-testing-for-lung-cancer-in-2019-perspective-from-the-iaslc-pathology/)
- [The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/the-promises-and-challenges-of-tumor-mutation-burden-as-an-immunotherapy/)
- [Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids](https://scholariq.org/papers/integrative-and-comparative-genomic-analyses-identify-clinically-relevant/)
- [Grading the neuroendocrine tumors of the lung: an evidence-based proposal](https://scholariq.org/papers/grading-the-neuroendocrine-tumors-of-the-lung-an-evidence-based-proposal/)
- [Lung cancer screening with low-dose computed tomography: A non-invasive diagnostic protocol for baseline lung nodules](https://scholariq.org/papers/lung-cancer-screening-with-low-dose-computed-tomography-a-non-invasive/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Researcher university

- [University of Milan](https://scholariq.org/institutions/university-of-milan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.